The FDA daily adverse event dashboard updates are designed to provide faster access to safety information for drugs and biologics. By offering FDA daily adverse event dashboard updates, the agency aims to reduce delays and improve the transparency of reported data. Background on the FAERS System The FDA Adverse Event […]
Report 97: Pfizer Obscured Myocarditis Safety Signal Specific to Young Men. FDA Took Five Months to Notice Pfizer’s Obfuscation.
Career scientists are struggling with attention to detail in fulfilling their vaccine safety duties. Their conclusions, marked by errors and oversights, have led to lives lost and debilitating disorders, as proven by the government scientists’ own review documents. In spring 2021, the US Food and Drug Administration (FDA) granted emergency […]
Report 93: Pfizer’s ‘Post-Marketing Surveillance Report’ Reveals That Pfizer Manipulated Data and Wrongly Tabulated Adverse Events, Which Concealed Them.
We evaluated Pfizer’s 38-page “5.3.6 Cumulative Analysis of Post-Authorization Adverse Events Reports of PF-07302048 (BNT162b2) received through 28-Feb-2021,” commonly known as “5.3.6,” starting in September of 2022. Patterns emerged across the System Organ Classes (SOCs). These patterns included Pfizer’s apparent concealment of various cases of adverse events, as well as […]
“To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older” – Latest version (submitted July 14, 2023) on ClinicalTrials.gov
“The Safety of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older,” eh? Hmm. I was under the impression that if you are pregnant, or hoping to be, you shouldn’t do certain things like drink alcohol, smoke cigarettes, and get injected with experimental transfecting agents. You […]
Report 73: Pfizer Knew by November 2020 That Its mRNA COVID Vaccine Was Neither Safe Nor Effective. Here Is What Pfizer’s Employees and Contractors Knew and When They Knew It.
Introduction Through the review of two documents – Pharmacovigilance Plan for Biologic License Application #125742 Of Covid-19 mRNA vaccine (nucleoside modified) (BNT162b2, PF-07302048) and 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162b2) Received Through 28-Feb-2021 – referred to below as “PV” and “5.3.6,” the contributors to this […]